561 related articles for article (PubMed ID: 24592911)
1. Periodontal status and high-sensitivity C-reactive protein levels in polycystic ovary syndrome with and without medical treatment.
Porwal S; Tewari S; Sharma RK; Singhal SR; Narula SC
J Periodontol; 2014 Oct; 85(10):1380-9. PubMed ID: 24592911
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyproterone acetate/ethinyl estradiol combination on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome: a cross-sectional study.
Singhal R; Tewari S; Sharma R; Singhal S; Tanwar N; Sangwan A
Quintessence Int; 2024 Apr; 55(4):274-285. PubMed ID: 38391191
[TBL] [Abstract][Full Text] [Related]
3. Periodontitis in coronary heart disease patients: strong association between bleeding on probing and systemic biomarkers.
Bokhari SA; Khan AA; Butt AK; Hanif M; Izhar M; Tatakis DN; Ashfaq M
J Clin Periodontol; 2014 Nov; 41(11):1048-54. PubMed ID: 24946826
[TBL] [Abstract][Full Text] [Related]
4. Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?
Özçaka Ö; Buduneli N; Ceyhan BO; Akcali A; Hannah V; Nile C; Lappin DF
J Periodontol; 2013 Dec; 84(12):1827-37. PubMed ID: 23327719
[TBL] [Abstract][Full Text] [Related]
5. Serum lipoprotein-associated phospholipase A₂ and C-reactive protein levels in association with periodontal disease and hyperlipidemia.
Fentoğlu O; Köroğlu BK; Kara Y; Doğan B; Yılmaz G; Sütçü R; Ay ZY; Tonguç MÖ; Orhan H; Tamer MN; Kırzıoğlu FY
J Periodontol; 2011 Mar; 82(3):350-9. PubMed ID: 20809860
[TBL] [Abstract][Full Text] [Related]
6. Serum plasminogen activator inhibitor-1 and tumor necrosis factor-α levels in obesity and periodontal disease.
Akman PT; Fentoğlu O; Yılmaz G; Arpak N
J Periodontol; 2012 Aug; 83(8):1057-62. PubMed ID: 22141357
[TBL] [Abstract][Full Text] [Related]
7. Assessment of high-sensitivity C-reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis--a cross-sectional study.
Kumar KR; Ranganath V; Naik R; Banu S; Nichani AS
J Periodontal Res; 2014 Dec; 49(6):836-44. PubMed ID: 24620793
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and severity of periodontitis in Indonesian patients with rheumatoid arthritis.
Susanto H; Nesse W; Kertia N; Soeroso J; Huijser van Reenen Y; Hoedemaker E; Agustina D; Vissink A; Abbas F; Dijkstra PU
J Periodontol; 2013 Aug; 84(8):1067-74. PubMed ID: 23075431
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein as a marker of periodontal disease.
Kanaparthy R; Kanaparthy A; Mahendra M
Gen Dent; 2012; 60(1):e1-5. PubMed ID: 22313986
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis.
Mayer Y; Balbir-Gurman A; Machtei EE
J Periodontol; 2009 Sep; 80(9):1414-20. PubMed ID: 19722791
[TBL] [Abstract][Full Text] [Related]
11. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
12. Is there an interaction between polycystic ovary syndrome and gingival inflammation?
Özçaka Ö; Ceyhan BÖ; Akcali A; Biçakci N; Lappin DF; Buduneli N
J Periodontol; 2012 Dec; 83(12):1529-37. PubMed ID: 22509751
[TBL] [Abstract][Full Text] [Related]
13. The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome.
Yilmaz MA; Duran C; Basaran M
J Endocrinol Invest; 2016 Jan; 39(1):45-53. PubMed ID: 26100531
[TBL] [Abstract][Full Text] [Related]
14. Effect of Non-Surgical Periodontal Therapy Along With Myo-Inositol on High-Sensitivity C-Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial.
Deepti ; Tewari S; Narula SC; Singhal SR; Sharma RK
J Periodontol; 2017 Oct; 88(10):999-1011. PubMed ID: 28598285
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
16. Investigating the association between obstructive sleep apnea and periodontitis.
Loke W; Girvan T; Ingmundson P; Verrett R; Schoolfield J; Mealey BL
J Periodontol; 2015 Feb; 86(2):232-43. PubMed ID: 25299385
[TBL] [Abstract][Full Text] [Related]
17. Association between metabolic syndrome and periodontal disease measures in postmenopausal women: the Buffalo OsteoPerio study.
LaMonte MJ; Williams AM; Genco RJ; Andrews CA; Hovey KM; Millen AE; Browne RW; Trevisan M; Wactawski-Wende J
J Periodontol; 2014 Nov; 85(11):1489-501. PubMed ID: 24857320
[TBL] [Abstract][Full Text] [Related]
18. Gingival crevicular fluid alkaline phosphatase levels in postmenopausal women: effects of phase I periodontal treatment.
Daltaban O; Saygun I; Bal B; Baloş K; Serdar M
J Periodontol; 2006 Jan; 77(1):67-72. PubMed ID: 16579705
[TBL] [Abstract][Full Text] [Related]
19. Association between periodontitis and systemic inflammation in patients with end-stage renal disease.
Nadeem M; Stephen L; Schubert C; Davids MR
SADJ; 2009 Nov; 64(10):470-3. PubMed ID: 20306866
[TBL] [Abstract][Full Text] [Related]
20. Impact of Polycystic Ovary Syndrome on Periodontal Status of Women of Adolescent and Adult Age Groups: A Cross-Sectional Study.
Jaglan S; Tewari S; Singhal SR; Sharma RK
Med Princ Pract; 2024; 33(2):148-156. PubMed ID: 38211576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]